Showing results (61-70 of 422) with videos related to
Sort By:
Pageof 43
Trends in Cancer|November 19, 2022
The emerging field of oncolytic virus-based cancer immunotherapyRui Ma, Zhenlong Li, E Antonio Chiocca, et al.Proceedings of the National Academy of Sciences of the United States of America|June 17, 2003
Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndromeJohn H Griffin, Joey Leung, Rebecca J Bruner, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 31, 2010
Immature NK cells, capable of producing IL-22, are present in human uterine mucosaVictoria Male, Tiffany Hughes, Susan McClory, et al.Blood|August 30, 2002
Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effectSherif S Farag, Todd A Fehniger, Loredana Ruggeri, et al.NPJ Precision Oncology|May 13, 2026
First-in-human study of FLT3 CAR-T cell therapy for relapsed acute myeloid leukemiaXiaojin Wu, Gao Lu, Lei Tian, et al.Annual Review of Pathology|May 20, 2016
Obesity, Inflammation, and CancerTuo Deng, Christopher J Lyon, Stephen Bergin, et al.Trends in Immunology|December 31, 2003
NK cell and DC interactionsMegan A Cooper, Todd A Fehniger, Anja Fuchs, et al.Plos One|September 12, 2008
Tumor growth decreases NK and B cells as well as common lymphoid progenitorJohn Richards, Beth McNally, Xianfeng Fang, et al.Expert Opinion on Biological Therapy|March 29, 2003
New directions in natural killer cell-based immunotherapy of human cancerSherif S Farag, Todd A Fehniger, Brian Becknell, et al.Advances in Virology|February 8, 2012
Deciphering the Multifaceted Relationship between Oncolytic Viruses and Natural Killer CellsChristopher A Alvarez-Breckenridge, Jianhua Yu, Balveen Kaur, et al.Pageof 43